Prepared Remarks:

Operator

Ladies and gentlemen, good morning and welcome to the CVS Health fourth quarter and full year 2022 earnings conference call. As a reminder, today's conference is being recorded. I would now like to turn the call over to Tom Cowhey, senior vice president of capital markets for CVS Health. Please go ahead.

Tom Cowhey -- Senior Vice President, Capital Markets

Good morning, and welcome to the CVS Health fourth quarter and full year 2022 earnings call and webcast. I'm Tom Cowhey, senior vice president of capital markets for CVS Health. I'm joined this morning by Karen Lynch, president and chief executive officer of CVS; Shawn Guertin, executive vice president and chief financial officer of CVS; and Mike Pykosz, chairman, CEO, and co-founder of Oak Street Health. Following our prepared remarks, we will host a question-and-answer session that will include additional members of the CVS management team: Daniel Finke, president, healthcare benefits; Michelle Peluso, chief customer officer and retail co-president; Prem Shah, chief pharmacy officer and retail co-president; David Joyner, new president, pharmacy services; and Dr.

Alan Lotvin, outgoing president, pharmacy services. Our earnings and Oak Street acquisition press releases and slide presentations have been posted to our website, along with our Form 10-K and our Form 8-K that we filed this morning with the SEC. Today's call is also being broadcast on our website, where it will be archived for one year. During this call, we will make certain forward-looking statements reflecting current views related to our future financial performance, future events, industry and market conditions, including impacts related to the ongoing COVID-19 pandemic, as well as the expected consumer benefits of our products and services, and our financial projections, and the benefits of the pending acquisitions of Signify Health and Oak Street Health and the associated integration plans, expected synergies, and revenue opportunities.

Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results, including with respect to the ongoing COVID-19 pandemic and the pending acquisition integration of Signify health. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties, in particular those that are described in the cautionary statement concerning forward-looking statements and the risk factors section in this morning's earnings press release, Oak Street Health acquisition press release, including our Form 10-K and the Form 8-K we filed this morning. During this call, we will use non-GAAP measures when talking about the company's performance and financial condition. And you can find a reconciliation of these non-GAAP measures in this morning's press release and the reconciliation document posted to the investor relations portion of our website.